Clinical Cardiology
RSSArticles
-
Atrial Fibrillation Ablation in Heart Failure Patients May Be Particularly Beneficial
Atrial fibrillation ablation leads to better outcomes in heart failure patients compared to amiodarone.
-
Rivaroxaban in the Real World
A large Phase IV registry study shows that rivaroxaban is associated with a very low incidence of major bleeding, death, or stroke. Also, adherence to therapy was much higher than observed in other studies with vitamin K antagonists.
-
New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit
It shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin.
-
Can Chemotherapy Damage Heart Valves?
Long-term lymphoma survivors were noted to experience valvular regurgitation out of proportion to reductions in left ventricular function and degenerative valve stenosis. The most evidence appeared in those who received radiation therapy in addition to chemotherapy.
-
Postoperative Atrial Fibrillation Management — You Can’t Go Wrong
Rate control and rhythm control strategies for cardiac surgery patients with postoperative atrial fibrillation lead to similar hospital durations, similar complication rates, and similar very low rates of atrial fibrillation at 60-day follow-up.
-
Can CABG Really Improve Left Ventricular Function?
In implantable cardioverter defibrillator candidates with an ejection fraction < 35% who underwent coronary artery bypass graft surgery, mean ejection fraction improved significantly, especially in those with baseline ejection fraction between 25-35%, obviating the need for an implantable cardioverter defibrillator in 58%.
-
CABG Improves Long-term Survival in Severe Left Ventricular Dysfunction
In patients with coronary artery disease, heart failure, and left ventricular ejection fraction < 35%, coronary artery bypass grafting plus medical therapy was associated with improved survival compared to medical therapy alone.
-
TAVR in Intermediate-risk Patients: How Low Can We Go?
Transcatheter and surgical aortic valve replacement in an intermediate-risk population have similar rates of death and disabling stroke at two years.
-
The Current Outlook for Cardiac Tamponade
In the modern era, cardiac tamponade is most commonly caused by malignancies with poor prognosis. As compared to older literature, iatrogenic causes have increased, most resulting from complications of percutaneous coronary intervention.
-
Ventricular Tachycardia Ablation for Recurrent Arrhythmia and Coronary Artery Disease
Acute and long-term success rates with ventricular tachycardia ablation in patients with coronary artery disease are relatively high with an acceptably low complication rate.